Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
GLP-1 agonist drugs licensed for type 2 diabetes or in phase III studies.
| Generic name | Trade name | Dosing schedule | Dose range | Company |
|---|---|---|---|---|
| Exenatide | Byetta | Twice daily | 5–10 μg | Lilly |
| Liraglutide | Victoza | Once daily | 0.6–1.8 mg | NovoNordisk |
| Exenatide LAR | Bydureon | Once weekly | 2 mg | Lilly/Amylin/Alkermes |
| Taspoglutide | N/A | Once weekly | 10–20 mg | Roche/Ipsen |
| Albiglutide | Syncria | Once weekly | 30 mg | GSK |
| Lixisenatide | N/A | Once daily | 10–20 μg | Sanofi-Aventis |
